StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$9.20+0.07 (+0.77%)

Close on Nov 17, 2026Market cap $821.53MP/E –Yield –

Syndax Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Syndax Pharmaceuticals's EV/EBITDA was 817.8× on Oct 31, 2022.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Oct 31, 2022817.8×–

More Syndax Pharmaceuticals figures

See a number that looks wrong?